Legend Biotech Corp (LEGN) Receivables - Net (2019 - 2024)
Legend Biotech (LEGN) has disclosed Receivables - Net for 6 consecutive years, with $6.3 million as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Receivables - Net fell 93.72% year-over-year to $6.3 million, compared with a TTM value of $6.3 million through Dec 2024, down 93.72%, and an annual FY2024 reading of $6.3 million, down 93.72% over the prior year.
- Receivables - Net was $6.3 million for Q4 2024 at Legend Biotech, down from $100.0 million in the prior quarter.
- Across five years, Receivables - Net topped out at $100.0 million in Q4 2023 and bottomed at $90000.0 in Q4 2022.
- Average Receivables - Net over 5 years is $46.4 million, with a median of $50.4 million recorded in 2021.
- The sharpest move saw Receivables - Net crashed 99.82% in 2022, then soared 111056.67% in 2023.
- Year by year, Receivables - Net stood at $75.0 million in 2020, then tumbled by 32.79% to $50.4 million in 2021, then plummeted by 99.82% to $90000.0 in 2022, then skyrocketed by 111056.67% to $100.0 million in 2023, then crashed by 93.72% to $6.3 million in 2024.
- Business Quant data shows Receivables - Net for LEGN at $6.3 million in Q4 2024, $100.0 million in Q4 2023, and $90000.0 in Q4 2022.